40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
2337.50%
Cash & equivalents yoy growth at least 1.5x SD's 41.89%. Mohnish Pabrai might see this as a favorable liquidity edge, provided funds are well deployed.
No Data
No Data available this quarter, please select a different quarter.
2337.50%
Cash + STI yoy ≥ 1.5x SD's 41.89%. David Dodd might see it as a strategic cash buffer advantage. Evaluate deployment plans.
-1.74%
Receivables growth less than half of SD's -26.77%. David Dodd might see more conservative credit practices, provided revenue isn't suffering.
No Data
No Data available this quarter, please select a different quarter.
6700.00%
Higher Other Current Assets Growth compared to SD's zero value, indicating worse performance.
19.50%
0.75-0.9x SD's 24.67%. Bill Ackman would ask if competitor is building short-term resources more aggressively.
12.81%
≥ 1.5x SD's 3.89%. David Dodd sees more aggressive capex. Confirm it's not overspending.
0.15%
Higher Goodwill Growth compared to SD's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
0.15%
Higher Goodwill + Intangibles Growth compared to SD's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-98.45%
Above 1.5x SD's -7.26%. Michael Burry warns of potential hidden liabilities or intangible bloat.
1.30%
Below half of SD's 3.86%. Michael Burry might suspect stagnation or lack of resources for expansions.
No Data
No Data available this quarter, please select a different quarter.
3.07%
Below half of SD's 12.47%. Michael Burry sees a potential red flag for stagnation or capital shortage.
-81.57%
Above 1.5x SD's -13.70%. Michael Burry questions if payables are being stretched to avoid short-term borrowing.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
41125.00%
Higher Deferred Revenue (Current) Growth compared to SD's zero value, indicating better performance.
-27.37%
Exceeding 1.5x SD's -15.38%. Michael Burry suspects ballooning short-term obligations vs. competitor.
-17.99%
Above 1.5x SD's -5.29%. Michael Burry sees a red flag for liquidity risk vs. competitor.
-0.10%
Higher Long-Term Debt Growth compared to SD's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-31.63%
Less than half of SD's 14.42%. David Dodd notes more conservative expansions in non-current obligations.
-3.93%
Less than half of SD's 14.42%. David Dodd sees a more conservative approach to non-current liabilities.
No Data
No Data available this quarter, please select a different quarter.
-8.72%
Less than half of SD's 1.82%. David Dodd sees far fewer liability expansions relative to competitor.
No Data
No Data available this quarter, please select a different quarter.
23.13%
≥ 1.5x SD's 3.91%. David Dodd sees higher yoy retained profits than competitor.
2.25%
Higher AOCI Growth compared to SD's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
33.63%
≥ 1.5x SD's 17.88%. David Dodd sees stronger capital base growth than competitor.
3.07%
Below half SD's 12.47%. Michael Burry sees significant shrinkage or inactivity vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
-0.22%
Higher Total Debt Growth compared to SD's zero value, indicating worse performance.
-3.46%
Less than half of SD's -41.89%. David Dodd sees better deleveraging or stronger cash buildup than competitor.